Significantly Increased Productivity Icon
Using fast-growing yeast dramatically reduces fermentation time and increases the product mass per volume per hour.
Itaconic Acid is a key building block for Bio-monomers Resins/Adhesives e.g. superabsorbent polymers, synthetic latex. The traditional production method faces challenges: Traditional fungal fermentation Aspergillus terreus is slow and limited by cell physiology. The resulting low pH limits cell growth and increases the high cost of purification due to acid neutralization and downstream separation.
CD Biosynsis offers a next-generation metabolic engineering platform for Itaconic Acid production: Metabolic Engineering: Transfer the Itaconic Acid pathway to industrial yeast S. cerevisiae or Y. lipolytica . Yeast offers faster growth and higher industrial scalability. We maximize the carbon flux by focusing on: Enhance the cis-Aconitate precursor supply and overexpress cis-Aconitate Decarboxylase CadA . CadA is the key rate-limiting enzyme. To ensure high-titer production, we address host tolerance through Toxicity Tolerance: Engineer hosts for tolerance to high acid concentration , enabling high-density fermentation at lower pH for cheaper downstream processing.
Get a QuoteThe microbial production of Itaconic Acid faces these key challenges:
A successful bio-based strategy must combine high-efficiency host metabolism with high acid tolerance.
CD Biosynsis utilizes integrated metabolic and host engineering to optimize Itaconic Acid production:
Industrial Host Switching
We transfer the full pathway to robust, fast-growing industrial yeasts S. cerevisiae or Y. lipolytica to achieve higher cell density and faster fermentation kinetics.
Flux and CadA Overexpression
We use metabolic engineering to increase the availability of cis-Aconitate precursor from the Krebs cycle and overexpress the rate-limiting enzyme CadA cis-Aconitate Decarboxylase .
Acid Toxicity Tolerance
We engineer the cell membrane, proton pumps, and stress response pathways to improve cell viability under high external acid concentrations , enabling low-pH fermentation.
Optimized Carbon Source Utilization
We tune the host for efficient consumption of cheap, alternative carbon sources e.g. glycerol or lignocellulosic sugars, reducing raw material costs. [Image of High Conversion Efficiency Icon]
This integrated approach maximizes productivity, reduces downstream costs, and increases overall economic viability.
Our Itaconic Acid engineering service is dedicated to pursuing the following production goals:
Significantly Increased Productivity Icon
Using fast-growing yeast dramatically reduces fermentation time and increases the product mass per volume per hour.
Lower Downstream Purification Cost Icon
Tolerance to low pH allows fermentation at the acid's pKa, minimizing neutralization and simplifying purification. [Image of Cost Reduction Icon]
Maximize Carbon Flux Icon
Combined precursor supply and CadA overexpression ensures high metabolic flow to the final product.
Robust Industrial Host Icon
Engineered industrial yeasts are amenable to large-scale fermentation and high-cell-density culture.
High Titer Achievement Icon
Improved acid tolerance and metabolic efficiency enable the strain to accumulate high concentrations of Itaconic Acid.
We deliver a high-productivity, cost-effective yeast cell factory for sustainable Itaconic Acid production.
Our Itaconic Acid strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a high-productivity, low-cost Itaconic Acid supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is CadA cis-Aconitate Decarboxylase the key enzyme?
CadA is the enzyme that performs the final, unique step in the Itaconic Acid pathway, converting cis-Aconitate to Itaconic Acid. Its activity is typically the major rate-limiting factor in non-native producers. Overexpressing a highly active version of CadA is essential to drain the cis-Aconitate precursor and achieve high flux toward the target product.
How does improving acid tolerance reduce purification cost?
Itaconic acid is best purified as its non-dissociated acid form, which requires low pH. If the fermentation can be conducted at a low pH e.g. pH 2.5-3.0 due to increased host tolerance, there is no need for costly pH adjustment and neutralization with bases, eliminating the formation of large amounts of salt byproducts, which simplifies and cheapens the downstream separation process.
Why are yeasts S. cerevisiae or Y. lipolytica preferred over the native A. terreus?
Industrial yeasts offer significant advantages: they have much faster growth rates , which leads to higher productivity, they can be readily engineered using established tools, and they are capable of achieving higher cell densities in submerged fermentation, which is essential for industrial scale-up and high final product titer.
How is the cis-Aconitate precursor supply enhanced?
cis-Aconitate is an intermediate in the Krebs cycle. We enhance its supply by overexpressing upstream enzymes e.g. Citrate Synthase and by downregulating competing enzymes e.g. Isocitrate Dehydrogenase that draw cis-Aconitate away into the rest of the Krebs cycle. This ensures that the CadA enzyme has a maximal supply of precursor to convert to Itaconic Acid.
What is the estimated project timeline?
A comprehensive project involving pathway transfer, metabolic flux tuning, and acid tolerance engineering typically requires 24-32 weeks for final strain delivery and validated high-productivity fermentation protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.